These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 19501213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.
    Cagnacci A, Ferrari S, Tirelli A, Zanin R, Volpe A.
    Contraception; 2009 Feb; 79(2):111-6. PubMed ID: 19135567
    [Abstract] [Full Text] [Related]

  • 3. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Feb; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 4. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M.
    Acta Obstet Gynecol Scand Suppl; 1997 Feb; 164():63-5. PubMed ID: 9225641
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL, Menard J, Rad M, Burggraaf J, de Kam ML, Tokay BA, Sivin I, Kluft C.
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [Abstract] [Full Text] [Related]

  • 8. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R.
    Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
    [Abstract] [Full Text] [Related]

  • 9. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH, Sudik R.
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [Abstract] [Full Text] [Related]

  • 10. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
    Massaro M, Di Carlo C, Gargano V, Formisano C, Bifulco G, Nappi C.
    Contraception; 2010 Mar; 81(3):209-14. PubMed ID: 20159176
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
    Vree ML, Schmidt J.
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
    [Abstract] [Full Text] [Related]

  • 13. Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.
    Cagnacci A, Tirelli A, Renzi A, Paoletti AM, Volpe A.
    Contraception; 2006 Apr; 73(4):348-51. PubMed ID: 16531164
    [Abstract] [Full Text] [Related]

  • 14. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
    Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC.
    Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism.
    Guazzelli CA, Barreiros FA, Barbosa R, Torloni MR, Barbieri M.
    Contraception; 2012 Apr; 85(4):389-93. PubMed ID: 22067754
    [Abstract] [Full Text] [Related]

  • 19. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G.
    Lancet; 1999 Dec 11; 354(9195):2036-40. PubMed ID: 10636369
    [Abstract] [Full Text] [Related]

  • 20. Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
    O'Connell KJ, Osborne LM, Westhoff C.
    Contraception; 2005 Nov 11; 72(5):323-7. PubMed ID: 16246655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.